1. Home
  2. KLTR vs OBIO Comparison

KLTR vs OBIO Comparison

Compare KLTR & OBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kaltura Inc.

KLTR

Kaltura Inc.

HOLD

Current Price

$1.60

Market Cap

218.0M

Sector

Technology

ML Signal

HOLD

Logo Orchestra BioMed Holdings Inc.

OBIO

Orchestra BioMed Holdings Inc.

HOLD

Current Price

$5.11

Market Cap

253.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KLTR
OBIO
Founded
2006
2017
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
218.0M
253.9M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
KLTR
OBIO
Price
$1.60
$5.11
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
5
Target Price
$3.00
$14.25
AVG Volume (30 Days)
1.1M
294.8K
Earning Date
05-08-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
61.90
33.13
EPS
N/A
N/A
Revenue
$180,854,000.00
$33,482,000.00
Revenue This Year
$2.96
N/A
Revenue Next Year
$4.96
$12.43
P/E Ratio
N/A
N/A
Revenue Growth
1.20
1169.22
52 Week Low
$1.06
$2.20
52 Week High
$2.05
$5.78

Technical Indicators

Market Signals
Indicator
KLTR
OBIO
Relative Strength Index (RSI) 52.51 64.97
Support Level $1.56 $3.72
Resistance Level $1.68 $5.42
Average True Range (ATR) 0.08 0.31
MACD -0.02 0.04
Stochastic Oscillator 38.02 63.92

Price Performance

Historical Comparison
KLTR
OBIO

About KLTR Kaltura Inc.

Kaltura Inc provides live and on-demand video SaaS solutions to thousands of organizations around the world, engaging hundreds of millions of viewers at home, at work, and at school. It also offers specialized industry solutions, including Learning Management System Video, Lecture Capture, and Virtual Classroom for educational institutions, as well as a TV Solution for media and telecom companies. It operates in two reporting segments which are Enterprise, Education, and Technology, and Media and Telecom. The majority of the revenue is derived from Enterprise, Education & Technology. The majority of the revenue is earned from the United States.

About OBIO Orchestra BioMed Holdings Inc.

Orchestra BioMed Holdings Inc is a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships with medical device companies. The company's flagship product candidates are Atrioventricular Interval Modulation Therapy (AVIM Therapy) for the treatment of hypertension, the risk factor for death, and Virtue Sirolimus AngioInfusion Balloon (Virtue SAB) for the treatment of atherosclerotic artery disease, the cause of mortality. It has one reportable segment, which consists of the development of clinical and preclinical product candidates through risk-reward sharing partnerships with medical device companies.

Share on Social Networks: